Zhongyuan Xu

发表

Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib.

Yang Liu, Fansheng Ran, Guisen Zhao, 2021, European journal of medicinal chemistry.

TME-targeting theranostic agent uses NIR tracking for tumor diagnosis and surgical resection and acts as chemotherapeutic showing enhanced efficiency and minimal toxicity

Hongmei Wu, Fansheng Ran, Peng Li, 2022, Theranostics.

Integrated transcriptomic and metabolomic analysis of rat serum to investigate potential target of puerarin in the treatment post-traumatic stress disorder

Zhongyuan Xu, Aishan Su, Xiaoyun Chen, 2021, Annals of translational medicine.

Integrated transcriptomic and metabolomic analysis of rat serum to investigate potential target of puerarin in the treatment posttraumatic stress disorder

Zijing Zhang, Zhongyuan Xu, Aishan Su, 2021 .

Piperlonguminine and Piperine Analogues as TrxR Inhibitors that Promote ROS and Autophagy and Regulate p38 and Akt/mTOR Signaling.

Wei Zhang, Yong Ling, Jianqiang Qian, 2020, Journal of natural products.

Design and synthesis of benzylidenecyclohexenones as TrxR inhibitors displaying high anticancer activity and inducing ROS, apoptosis, and autophagy.

Yong Ling, K. Lee, Jianqiang Qian, 2020, European journal of medicinal chemistry.

Development of novel nitric oxide-releasing quinolinedione/furoxan hybrids as NQO1 inhibitors for intervention of drug-resistanthepatocellular cancer.

Yi-Chia Wang, Hongmei Wu, Yong Ling, 2022, Bioorganic chemistry.

Overview of piperlongumine analogues and their therapeutic potential.

Fansheng Ran, Wei Zhang, Yong Ling, 2021, European journal of medicinal chemistry.

GSH/ROS Dual-Responsive Supramolecular Nanoparticles Based on Pillar[6]arene and Betulinic Acid Prodrug for Chemo–Chemodynamic Combination Therapy

Yong Ling, Jianqiang Qian, Chi Meng, 2021, Molecules.

Recent development of BTK-based dual inhibitors in the treatment of cancers.

Fansheng Ran, Yong Ling, Jianqiang Qian, 2022, European journal of medicinal chemistry.

Redox-Activatable Theranostic Co-Prodrug for Precise Tumor Diagnosis and Selective Combination Chemotherapy.

Hongmei Wu, Fansheng Ran, Yong Ling, 2022, Journal of medicinal chemistry.

A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma.

Fansheng Ran, Yong Ling, Jianqiang Qian, 2021, Journal of natural products.

Acidic tumor microenvironment-activatable fluorescent diagnostic probe for the rapid identification and resection of human tumors via spraying.

Yi-Chia Wang, Peng Li, Xudong Xie, 2023, Biosensors & bioelectronics.

Efficacy of novel methylenecyclohexenone derivatives as TrxR inhibitors in suppressing the proliferation and metastasis of human cancer cells.

Yong Ling, Jianqiang Qian, Ji Liu, 2020, Bioorganic chemistry.

A “Double-Locked” and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy

Yong Ling, Chi Meng, Yuquan Zhang, 2022, Molecules.